LEVEMIR PENFILL
LEVEMIR PENFILL
Approved
DIN Number
02271842
Drug Class
Human
Market Date
Nov 14, 2005
Company
HC
Novo Nordisk Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02271842
AIG Number0151541001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
A10AE05 INSULIN DETEMIR
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification68:20.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
INSULIN DETEMIRActive
Strength: 100 UNIT / ML
Monograph: INSULIN DETEMIR